TOCILIZUMAB

TOCILIZUMAB was reported 115272 times

TOCILIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 310 0.9226
1 DISABILITY ASSESSMENT SCALE SCORE INCREASED 267 0.8697
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5991 0.8353
3 RHEUMATOID FACTOR POSITIVE 4647 0.8037
4 RHEUMATOID FACTOR NEGATIVE 138 0.7886
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 526 0.7874
6 SWOLLEN JOINT COUNT INCREASED 2454 0.7688
7 RHEUMATIC FEVER 3395 0.7609
8 RED BLOOD CELL SEDIMENTATION RATE 208 0.7455
9 PEMPHIGUS 9308 0.7437
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 1423 0.7104
11 DUODENAL ULCER PERFORATION 5126 0.6886
12 C-REACTIVE PROTEIN 626 0.6753
13 LUPUS VULGARIS 841 0.6675
14 GRANULOMA SKIN 525 0.6395
15 FACET JOINT SYNDROME 2037 0.6250
16 HEPATIC ENZYME 92 0.6174
17 SWOLLEN JOINT COUNT 154 0.6160
18 HAND DEFORMITY 8087 0.6160
19 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1384 0.6002
20 C-REACTIVE PROTEIN ABNORMAL 3814 0.5940
21 GRIP STRENGTH 136 0.5939
22 SYNOVITIS 10657 0.5904
23 MUSCULOSKELETAL DEFORMITY 135 0.5769
24 X-RAY ABNORMAL 964 0.5385
25 MUSCLE INJURY 4265 0.5142
26 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1053 0.5077
27 HELICOBACTER INFECTION 5213 0.5067
28 BODY HEIGHT BELOW NORMAL 323 0.5023
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3168 0.4873
30 PRESBYACUSIS 147 0.4773
31 DISLOCATION OF VERTEBRA 1071 0.4691
32 FOLLICULITIS 4768 0.4542
33 BONE EROSION 1589 0.4489
34 JOINT LAXITY 131 0.4338
35 BLOOD PARATHYROID HORMONE DECREASED 612 0.4127
36 ANTICIPATORY ANXIETY 110 0.4044
37 CONTRAINDICATED PRODUCT ADMINISTERED 12254 0.4043
38 RETINITIS 697 0.4031
39 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 221 0.3939
40 GLOSSODYNIA 8626 0.3849
41 PERICARDITIS 6306 0.3750
42 SERONEGATIVE ARTHRITIS 423 0.3691
43 SHORT STATURE 96 0.3664
44 PERIPHERAL VENOUS DISEASE 1476 0.3611
45 RHEUMATOID NODULE 994 0.3605
46 BLOOD IRON ABNORMAL 348 0.3562
47 BLOOD PRESSURE DIASTOLIC ABNORMAL 896 0.3519
48 DRUG TOLERANCE DECREASED 933 0.3319
49 BLOOD PRESSURE SYSTOLIC ABNORMAL 815 0.3294
50 ANKLE ARTHROPLASTY 112 0.3085
51 JOINT DESTRUCTION 466 0.2995
52 INTESTINAL SEPSIS 78 0.2977
53 PANNICULITIS 680 0.2808
54 LOOSE BODY IN JOINT 74 0.2782
55 SYSTEMIC LUPUS ERYTHEMATOSUS 9841 0.2770
56 WOUND 7390 0.2641
57 HYPOCHOLESTEROLAEMIA 93 0.2635
58 JUVENILE IDIOPATHIC ARTHRITIS 607 0.2480
59 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2727 0.2462
60 BREAST CANCER STAGE III 1582 0.2440
61 TEMPERATURE REGULATION DISORDER 530 0.2377
62 ONYCHOMADESIS 941 0.2240
63 BURSITIS 2662 0.2192
64 GRIP STRENGTH DECREASED 1912 0.2170
65 IRRITABLE BOWEL SYNDROME 4658 0.2170
66 PORPHYRIA ACUTE 311 0.2167
67 GIANT CELL ARTERITIS 178 0.2142
68 LIP DRY 1945 0.2139
69 JOINT RANGE OF MOTION DECREASED 2800 0.2086
70 RHEUMATOID LUNG 198 0.2073
71 AMAUROSIS FUGAX 222 0.2061
72 ONYCHOMYCOSIS 894 0.2036
73 OVERLAP SYNDROME 142 0.2029
74 RHEUMATOID ARTHRITIS 23003 0.2024
75 HYPERCHOLESTEROLAEMIA 1944 0.2011
76 ARTHROPATHY 11013 0.1979
77 WOUND INFECTION 2030 0.1852
78 THERAPEUTIC PRODUCT EFFECT DECREASED 8079 0.1802
79 TENOSYNOVITIS 496 0.1796
80 PLEURAL THICKENING 119 0.1740
81 FIBROMYALGIA 4177 0.1716
82 BONE CYST 157 0.1674
83 JOINT ANKYLOSIS 93 0.1637
84 ANTIBODY TEST POSITIVE 269 0.1620
85 IMPAIRED HEALING 5321 0.1619
86 NAIL OPERATION 67 0.1618
87 BLEPHAROSPASM 1012 0.1606
88 FINGER DEFORMITY 750 0.1547
89 LIVE BIRTH 1275 0.1523
90 AUTOIMMUNE DISORDER 1476 0.1513
91 PLEURAL FIBROSIS 152 0.1492
92 INFUSION RELATED REACTION 9572 0.1443
93 WRIST DEFORMITY 87 0.1415
94 INTERLEUKIN LEVEL INCREASED 78 0.1413
95 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 112 0.1404
96 MEAN PLATELET VOLUME DECREASED 117 0.1395
97 LIVER INJURY 3408 0.1387
98 VASCULAR ACCESS COMPLICATION 111 0.1370
99 JOINT SWELLING 16528 0.1368
100 DRUG INTOLERANCE 13224 0.1368
101 INFUSION SITE REACTION 399 0.1334
102 ARTHRODESIS 134 0.1316
103 COELIAC DISEASE 1288 0.1312
104 JOINT ARTHROPLASTY 235 0.1311
105 SCIATICA 2086 0.1307
106 POLYARTHRITIS 689 0.1306
107 NAIL DISORDER 1140 0.1302
108 BLOOD MAGNESIUM INCREASED 117 0.1297
109 OBESITY 2065 0.1295
110 HEPATIC ENZYME INCREASED 8784 0.1287
111 LOWER RESPIRATORY TRACT INFECTION 5757 0.1265
112 MATERNAL EXPOSURE TIMING UNSPECIFIED 465 0.1237
113 TREATMENT FAILURE 10225 0.1233
114 LIMB DEFORMITY 195 0.1226
115 SOFT TISSUE DISORDER 133 0.1199
116 ALLERGY TO CHEMICALS 148 0.1188
117 C-REACTIVE PROTEIN INCREASED 4325 0.1188
118 TYPE 2 DIABETES MELLITUS 3999 0.1187
119 TENOSYNOVITIS STENOSANS 66 0.1185
120 FOOT DEFORMITY 1310 0.1181
121 PULMONARY FIBROSIS 2258 0.1176
122 DEATH NEONATAL 161 0.1157
123 HIP ARTHROPLASTY 1771 0.1155
124 ENTHESOPATHY 180 0.1150
125 SWELLING 10597 0.1131
126 PSORIATIC ARTHROPATHY 4582 0.1128
127 INTERCEPTED PRODUCT STORAGE ERROR 401 0.1123
128 BLOOD PRESSURE DIASTOLIC INCREASED 513 0.1110
129 C-REACTIVE PROTEIN DECREASED 72 0.1103
130 SKIN NECROSIS 572 0.1101
131 BLOOD PRESSURE DIASTOLIC DECREASED 811 0.1098
132 EXOSTOSIS 985 0.1078
133 HYPOFIBRINOGENAEMIA 106 0.1069
134 INVESTIGATION ABNORMAL 146 0.1015
135 PRESCRIBED OVERDOSE 1926 0.0994
136 APPARENT DEATH 355 0.0985
137 DISCOMFORT 5891 0.0965
138 KNEE ARTHROPLASTY 2017 0.0957
139 BLOOD CHOLESTEROL INCREASED 4432 0.0950
140 BLISTER 5309 0.0944
141 DRUG SPECIFIC ANTIBODY 128 0.0934
142 STOMATITIS 5648 0.0930
143 FOOD ALLERGY 715 0.0925
144 LOWER RESPIRATORY TRACT CONGESTION 156 0.0917
145 LUPUS-LIKE SYNDROME 832 0.0917
146 DRUG TOLERANCE 449 0.0887
147 WALKING AID USER 573 0.0868
148 OSTEOARTHRITIS 3654 0.0861
149 IMMUNODEFICIENCY 1281 0.0858
150 ALANINE AMINOTRANSFERASE ABNORMAL 180 0.0853
151 BRONCHITIS CHRONIC 207 0.0847
152 PUSTULAR PSORIASIS 291 0.0846
153 PRODUCT LABEL CONFUSION 493 0.0845
154 MEAN CELL VOLUME DECREASED 130 0.0843
155 BACK INJURY 904 0.0830
156 ILL-DEFINED DISORDER 5046 0.0830
157 MUSCULOSKELETAL STIFFNESS 7213 0.0823
158 JOINT DISLOCATION 867 0.0819
159 LOWER LIMB FRACTURE 1574 0.0818
160 GAIT INABILITY 2721 0.0813
161 INFECTED BITE 68 0.0801
162 INFLAMMATION 4060 0.0786
163 LIVER FUNCTION TEST INCREASED 1675 0.0779
164 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3726 0.0775
165 JOINT STIFFNESS 2030 0.0773
166 BLOOD PRESSURE SYSTOLIC INCREASED 1506 0.0771
167 MEAN CELL HAEMOGLOBIN DECREASED 141 0.0770
168 PNEUMONIA VIRAL 240 0.0752
169 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 557 0.0741
170 NIGHT SWEATS 2357 0.0731
171 OSTEOPOROTIC FRACTURE 140 0.0731
172 MOBILITY DECREASED 5224 0.0726
173 IMMOBILE 317 0.0725
174 RHEUMATOID FACTOR INCREASED 81 0.0725
175 MATERNAL EXPOSURE DURING PREGNANCY 6434 0.0721
176 INTERCEPTED MEDICATION ERROR 333 0.0718
177 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 424 0.0715
178 ORAL MUCOSAL EXFOLIATION 106 0.0700
179 RETINAL TOXICITY 72 0.0699
180 SPONDYLITIS 254 0.0698
181 SYNOVIAL CYST 321 0.0695
182 FINE MOTOR SKILL DYSFUNCTION 197 0.0680
183 SURGICAL FAILURE 78 0.0674
184 EYE INJURY 204 0.0671
185 PRESCRIBED UNDERDOSE 1323 0.0663
186 JOINT EFFUSION 456 0.0661
187 EAR PAIN 1284 0.0660
188 PRURITUS ALLERGIC 77 0.0660
189 SCLERITIS 105 0.0655
190 BONE SWELLING 62 0.0640
191 BREAST CANCER STAGE II 532 0.0639
192 LIMB MASS 140 0.0637
193 ABDOMINAL DISCOMFORT 10676 0.0636
194 ULCER HAEMORRHAGE 429 0.0633
195 CONGENITAL ANOMALY 490 0.0632
196 MUSCULOSKELETAL PAIN 3295 0.0628
197 DIVERTICULAR PERFORATION 129 0.0626
198 INTENTIONAL PRODUCT USE ISSUE 5486 0.0626
199 FOETAL DEATH 321 0.0618
200 DEFORMITY 576 0.0616
201 PULMONARY TOXICITY 434 0.0613
202 DEMYELINATION 250 0.0609
203 DRUG ERUPTION 1072 0.0604
204 SYSTEMIC CANDIDA 151 0.0601
205 URINARY TRACT DISORDER 265 0.0588
206 ARTHRITIS BACTERIAL 241 0.0587
207 SINUSITIS 5997 0.0585
208 BODY TEMPERATURE DECREASED 576 0.0585
209 PERIPHERAL SWELLING 9007 0.0584
210 DRUG DELIVERY SYSTEM MALFUNCTION 297 0.0580
211 INFECTION 8401 0.0580
212 HEPATIC CIRRHOSIS 1085 0.0577
213 MUSCLE SPASTICITY 699 0.0568
214 BLOOD FIBRINOGEN DECREASED 64 0.0560
215 HYPERSENSITIVITY 10351 0.0557
216 SKIN ULCER 1441 0.0557
217 ALOPECIA 10836 0.0551
218 HYPERCALCAEMIA 666 0.0539
219 ARTHRITIS INFECTIVE 250 0.0538
220 HISTIOCYTOSIS HAEMATOPHAGIC 160 0.0538
221 GASTROINTESTINAL DISORDER 4826 0.0538
222 DIVERTICULITIS 1481 0.0534
223 SLEEP DISORDER 3762 0.0532
224 WHEELCHAIR USER 236 0.0530
225 RASH VESICULAR 256 0.0529
226 LIVER DISORDER 2320 0.0523
227 ADRENAL INSUFFICIENCY 633 0.0521
228 SPINAL COLUMN INJURY 115 0.0515
229 HEPATITIS 1318 0.0515
230 PRERENAL FAILURE 72 0.0511
231 NODULE 663 0.0508
232 LUNG DISORDER 2478 0.0505
233 BASAL CELL CARCINOMA 787 0.0504
234 CREPITATIONS 150 0.0503
235 COLITIS MICROSCOPIC 237 0.0500
236 GASTROINTESTINAL PERFORATION 206 0.0495
237 INFECTIOUS PLEURAL EFFUSION 75 0.0492
238 MONOCYTE COUNT INCREASED 179 0.0492
239 THERAPY NON-RESPONDER 2215 0.0492
240 DEAFNESS NEUROSENSORY 160 0.0486
241 OSTEOPOROSIS 1973 0.0479
242 WHEEZING 2836 0.0478
243 CUSHINGOID 153 0.0476
244 ULCER 756 0.0475
245 PNEUMONIA FUNGAL 187 0.0474
246 INJURY 3304 0.0470
247 CYTOKINE RELEASE SYNDROME 937 0.0467
248 CUTANEOUS VASCULITIS 169 0.0463
249 BLOOD PRESSURE FLUCTUATION 1104 0.0459
250 EPIGASTRIC DISCOMFORT 179 0.0458
251 NASAL ULCER 73 0.0458
252 CONTUSION 4338 0.0450
253 NEOPLASM SKIN 69 0.0444
254 GENERAL PHYSICAL HEALTH DETERIORATION 5139 0.0444
255 BODY TEMPERATURE INCREASED 901 0.0441
256 ARTHRITIS 3463 0.0440
257 SPINAL STENOSIS 181 0.0438
258 JOINT NOISE 86 0.0437
259 INTESTINAL POLYP 72 0.0437
260 RHEUMATIC DISORDER 84 0.0434
261 NORMAL NEWBORN 235 0.0432
262 OEDEMA 2338 0.0431
263 EXPOSURE DURING PREGNANCY 2655 0.0427
264 SKIN PAPILLOMA 170 0.0424
265 ARTHRALGIA 17524 0.0421
266 ROAD TRAFFIC ACCIDENT 1753 0.0419
267 PHYSICAL DISABILITY 185 0.0418
268 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2966 0.0417
269 VIRAL UPPER RESPIRATORY TRACT INFECTION 197 0.0414
270 TASTE DISORDER 839 0.0413
271 DRUG-INDUCED LIVER INJURY 1297 0.0413
272 SPINAL FUSION SURGERY 167 0.0411
273 BRONCHOPULMONARY ASPERGILLOSIS 319 0.0411
274 NASOPHARYNGITIS 7575 0.0411
275 RESPIRATORY DISORDER 1212 0.0405
276 ADVERSE REACTION 536 0.0404
277 DISABILITY 793 0.0401
278 OSTEOSCLEROSIS 62 0.0393
279 PNEUMONIA BACTERIAL 358 0.0390
280 NO ADVERSE EVENT 7009 0.0386
281 UPPER RESPIRATORY TRACT INFECTION 1752 0.0379
282 EPILEPSY 1156 0.0378
283 OSTEOLYSIS 77 0.0376
284 WHITE BLOOD CELL COUNT ABNORMAL 240 0.0376
285 INFECTED SKIN ULCER 71 0.0375
286 GROWTH RETARDATION 110 0.0373
287 TUBERCULIN TEST POSITIVE 94 0.0371
288 PREGNANCY 743 0.0371
289 JOINT INJURY 785 0.0367
290 BLOOD PRESSURE SYSTOLIC DECREASED 165 0.0362
291 EAR INFECTION 957 0.0359
292 PRODUCT USE ISSUE 6710 0.0357
293 PHARYNGITIS 440 0.0354
294 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 607 0.0354
295 INJECTION SITE HYPERSENSITIVITY 110 0.0351
296 GASTROINTESTINAL TOXICITY 169 0.0351
297 JOINT LOCK 99 0.0348
298 FOOT OPERATION 171 0.0345
299 NEUROGENIC BLADDER 72 0.0341
300 SUSPECTED OFF LABEL USE 153 0.0338
301 SKIN LACERATION 368 0.0338
302 COVID-19 PNEUMONIA 398 0.0337
303 WEIGHT INCREASED 7547 0.0337
304 HEPATIC ENZYME ABNORMAL 168 0.0336
305 HEART RATE DECREASED 1181 0.0336
306 DELIRIUM 1166 0.0336
307 PAIN 20420 0.0332
308 HAEMORRHAGIC STROKE 257 0.0329
309 MYOSITIS 294 0.0327
310 LOCALISED INFECTION 792 0.0327
311 CONDITION AGGRAVATED 9777 0.0321
312 NECK PAIN 1785 0.0319
313 RASH 13900 0.0319
314 HERPES ZOSTER 1815 0.0316
315 HYPERTENSION 6690 0.0316
316 CARDIOTOXICITY 279 0.0312
317 URTICARIA 5231 0.0312
318 LIPIDS INCREASED 63 0.0312
319 INTERSTITIAL LUNG DISEASE 1493 0.0308
320 HYPERTRANSAMINASAEMIA 214 0.0307
321 DRY MOUTH 2492 0.0307
322 DEVICE DEFECTIVE 531 0.0306
323 ANTINUCLEAR ANTIBODY POSITIVE 99 0.0304
324 CONFUSIONAL STATE 4857 0.0300
325 PULMONARY MASS 441 0.0296
326 MUSCULOSKELETAL DISORDER 559 0.0293
327 POOR VENOUS ACCESS 303 0.0293
328 OXYGEN SATURATION DECREASED 1640 0.0292
329 GENERAL SYMPTOM 217 0.0289
330 HEPATIC STEATOSIS 535 0.0287
331 HEPATOTOXICITY 638 0.0286
332 NECK MASS 81 0.0286
333 HAEMATOLOGICAL INFECTION 70 0.0286
334 PULMONARY THROMBOSIS 312 0.0286
335 THERAPEUTIC RESPONSE DECREASED 1720 0.0283
336 RED CELL DISTRIBUTION WIDTH INCREASED 117 0.0281
337 SKIN ABRASION 133 0.0281
338 DRUG USE DISORDER 234 0.0278
339 WEIGHT FLUCTUATION 291 0.0278
340 TERMINAL STATE 186 0.0278
341 INTESTINAL PERFORATION 309 0.0275
342 MOUTH ULCERATION 580 0.0275
343 APHTHOUS ULCER 213 0.0274
344 POLYMYALGIA RHEUMATICA 87 0.0274
345 TOOTH INFECTION 361 0.0274
346 BREATH SOUNDS ABNORMAL 135 0.0274
347 NECROTISING FASCIITIS 96 0.0272
348 HYPOAESTHESIA 4067 0.0271
349 DRUG INEFFECTIVE 35683 0.0270
350 HYPOGAMMAGLOBULINAEMIA 177 0.0269
351 RESPIRATORY RATE INCREASED 239 0.0269
352 SEPTIC SHOCK 1166 0.0268
353 SHOULDER ARTHROPLASTY 72 0.0267
354 TONGUE DISORDER 192 0.0265
355 ABSCESS LIMB 113 0.0265
356 PLEURISY 156 0.0262
357 MUCORMYCOSIS 68 0.0261
358 ORAL HERPES 507 0.0259
359 ULCERATIVE KERATITIS 71 0.0259
360 DYSPEPSIA 2520 0.0256
361 PRODUCT TEMPERATURE EXCURSION ISSUE 131 0.0255
362 GASTRIC INFECTION 97 0.0253
363 ASPERGILLUS INFECTION 165 0.0251
364 OSTEOMYELITIS 450 0.0248
365 TONGUE ULCERATION 83 0.0245
366 GRANULOMA 84 0.0242
367 MASS 336 0.0240
368 INFLAMMATORY MARKER INCREASED 119 0.0240
369 CYST 297 0.0239
370 OFF LABEL USE 20842 0.0238
371 TENDERNESS 248 0.0238
372 IMPAIRED WORK ABILITY 508 0.0237
373 LARGE INTESTINE PERFORATION 164 0.0236
374 BRONCHIECTASIS 159 0.0236
375 SENSITIVITY TO WEATHER CHANGE 124 0.0235
376 DERMATITIS ALLERGIC 296 0.0235
377 INJECTION SITE REACTION 1611 0.0234
378 DYSLIPIDAEMIA 118 0.0232
379 TOOTH ABSCESS 234 0.0230
380 TOOTH DISORDER 510 0.0229
381 TOOTHACHE 413 0.0228
382 LYMPHOPROLIFERATIVE DISORDER 67 0.0228
383 ENDOCARDITIS 116 0.0226
384 ASTHMA 2548 0.0225
385 PNEUMOCYSTIS JIROVECII PNEUMONIA 226 0.0225
386 LIGAMENT SPRAIN 222 0.0224
387 SKIN REACTION 316 0.0224
388 ERYSIPELAS 112 0.0223
389 CYTOMEGALOVIRUS VIRAEMIA 99 0.0222
390 MIGRAINE 2116 0.0221
391 KLEBSIELLA INFECTION 112 0.0221
392 ABDOMINAL PAIN UPPER 4557 0.0221
393 PAIN IN EXTREMITY 6516 0.0221
394 UVEITIS 299 0.0220
395 ENTEROCOCCAL INFECTION 106 0.0219
396 ALANINE AMINOTRANSFERASE INCREASED 1340 0.0218
397 OCULAR DISCOMFORT 245 0.0218
398 GENERALISED OEDEMA 270 0.0218
399 DRUG SPECIFIC ANTIBODY PRESENT 141 0.0217
400 HEPATIC FIBROSIS 74 0.0215
401 BRONCHITIS 1594 0.0215
402 GLAUCOMA 412 0.0214
403 THERMAL BURN 151 0.0213
404 FOOT FRACTURE 403 0.0212
405 RASH PRURITIC 1152 0.0212
406 HYPERKERATOSIS 117 0.0212
407 LEUKOPENIA 1059 0.0212
408 BACK DISORDER 344 0.0211
409 OSTEOPENIA 320 0.0211
410 CYTOMEGALOVIRUS INFECTION REACTIVATION 93 0.0210
411 BACTERIAL SEPSIS 68 0.0209
412 ASPARTATE AMINOTRANSFERASE INCREASED 1108 0.0208
413 EAR PRURITUS 73 0.0208
414 ADVERSE EVENT 1915 0.0208
415 FEMUR FRACTURE 638 0.0206
416 PYODERMA GANGRENOSUM 74 0.0205
417 BEDRIDDEN 270 0.0205
418 PYELONEPHRITIS 178 0.0205
419 CHRONIC SINUSITIS 77 0.0205
420 STAPHYLOCOCCAL BACTERAEMIA 89 0.0205
421 GASTROENTERITIS VIRAL 366 0.0203
422 LIVER FUNCTION TEST ABNORMAL 589 0.0202
423 FLUID RETENTION 1027 0.0202
424 VEIN DISORDER 101 0.0202
425 TENDON DISORDER 131 0.0201
426 AMNESIA 1307 0.0201
427 PNEUMONIA 6496 0.0200
428 FATIGUE 15546 0.0199
429 VASCULITIS 232 0.0199
430 MUSCULAR WEAKNESS 2253 0.0198
431 BONE DENSITY DECREASED 610 0.0194
432 PYREXIA 6714 0.0194
433 BACTERAEMIA 230 0.0194
434 FUNGAL SKIN INFECTION 78 0.0193
435 ADVERSE DRUG REACTION 1729 0.0192
436 CANDIDA INFECTION 323 0.0191
437 ANAPHYLACTIC REACTION 1056 0.0191
438 GASTRIC DISORDER 655 0.0191
439 MULTIPLE ALLERGIES 149 0.0190
440 SPINAL DISORDER 180 0.0190
441 LYMPHOCYTE COUNT INCREASED 62 0.0190
442 MALIGNANT MELANOMA 254 0.0189
443 SERUM FERRITIN INCREASED 100 0.0189
444 ENCEPHALITIS 130 0.0188
445 MEDICATION ERROR 1044 0.0188
446 SPINAL COMPRESSION FRACTURE 155 0.0187
447 VAGINAL INFECTION 88 0.0187
448 FEAR OF INJECTION 133 0.0186
449 SKIN INFECTION 207 0.0184
450 MENINGITIS 123 0.0184
451 DISSEMINATED INTRAVASCULAR COAGULATION 257 0.0182
452 RASH ERYTHEMATOUS 872 0.0182
453 TOOTH FRACTURE 201 0.0182
454 PARANASAL SINUS DISCOMFORT 69 0.0182
455 PRODUCT COMPLAINT 460 0.0181
456 TENDONITIS 281 0.0181
457 HYPERAESTHESIA 149 0.0181
458 CYSTITIS 575 0.0180
459 CYTOPENIA 221 0.0180
460 PRURITUS 6897 0.0179
461 PHOTOPHOBIA 337 0.0179
462 BLOOD PRESSURE INCREASED 2737 0.0179
463 CELLULITIS 902 0.0179
464 GAIT DISTURBANCE 3345 0.0175
465 IMMUNOSUPPRESSION 154 0.0174
466 ANAL ABSCESS 94 0.0174
467 HEAD DISCOMFORT 308 0.0174
468 INSOMNIA 4618 0.0173
469 INJECTION SITE INFLAMMATION 86 0.0172
470 LYMPHOEDEMA 119 0.0172
471 ORAL DISORDER 126 0.0172
472 BONE DISORDER 313 0.0172
473 SINUS CONGESTION 232 0.0172
474 GASTROOESOPHAGEAL REFLUX DISEASE 1377 0.0171
475 LIMB DISCOMFORT 527 0.0170
476 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 289 0.0170
477 GASTROENTERITIS 246 0.0168
478 THYROID DISORDER 259 0.0168
479 SECRETION DISCHARGE 209 0.0167
480 TONSILLITIS 87 0.0167
481 EYE INFECTION 187 0.0165
482 KIDNEY INFECTION 324 0.0165
483 BACTERIAL INFECTION 308 0.0165
484 MULTIPLE ORGAN DYSFUNCTION SYNDROME 465 0.0164
485 POST PROCEDURAL INFECTION 133 0.0163
486 HERPES VIRUS INFECTION 93 0.0161
487 GOITRE 66 0.0161
488 OEDEMA PERIPHERAL 1961 0.0161
489 BLINDNESS UNILATERAL 226 0.0160
490 ORAL DISCOMFORT 222 0.0160
491 GINGIVITIS 86 0.0159
492 ENTEROCOLITIS 92 0.0159
493 DIVERTICULUM 113 0.0159
494 ECCHYMOSIS 109 0.0159
495 ANKYLOSING SPONDYLITIS 209 0.0158
496 ARTHROPOD BITE 117 0.0158
497 THERAPY PARTIAL RESPONDER 246 0.0158
498 MEMORY IMPAIRMENT 2149 0.0156
499 HEADACHE 9780 0.0156
500 CARPAL TUNNEL SYNDROME 218 0.0156
501 VITAMIN D DECREASED 133 0.0155
502 WHITE BLOOD CELL COUNT INCREASED 592 0.0154
503 LIMB OPERATION 74 0.0154
504 CHEST PAIN 2852 0.0154
505 POSTOPERATIVE WOUND INFECTION 104 0.0154
506 SARCOIDOSIS 73 0.0154
507 PSEUDOMONAS INFECTION 131 0.0153
508 FRACTURE 289 0.0153
509 ACUTE RESPIRATORY DISTRESS SYNDROME 269 0.0152
510 ABSCESS 242 0.0152
511 HEPATIC FUNCTION ABNORMAL 564 0.0151
512 IMPAIRED GASTRIC EMPTYING 204 0.0149
513 DIFFUSE LARGE B-CELL LYMPHOMA 115 0.0149
514 BLINDNESS 604 0.0148
515 TRANSAMINASES INCREASED 325 0.0146
516 NERVE INJURY 162 0.0146
517 CATARACT 867 0.0145
518 WEIGHT DECREASED 4050 0.0145
519 PAIN IN JAW 409 0.0144
520 SEPSIS 1609 0.0144
521 SUBCUTANEOUS ABSCESS 69 0.0144
522 LIMB INJURY 391 0.0144
523 MALAISE 6304 0.0144
524 FUNGAL INFECTION 479 0.0144
525 PNEUMOTHORAX 227 0.0143
526 STRESS FRACTURE 77 0.0143
527 INTERVERTEBRAL DISC DEGENERATION 132 0.0143
528 PARAESTHESIA 2238 0.0142
529 ANKLE FRACTURE 220 0.0142
530 STAPHYLOCOCCAL SEPSIS 70 0.0142
531 UMBILICAL HERNIA 66 0.0141
532 SKIN WARM 82 0.0141
533 PRODUCT USE IN UNAPPROVED INDICATION 3486 0.0141
534 PHOTOSENSITIVITY REACTION 231 0.0140
535 UROSEPSIS 129 0.0140
536 CYTOMEGALOVIRUS INFECTION 232 0.0139
537 EPSTEIN-BARR VIRUS INFECTION 87 0.0139
538 MATERNAL EXPOSURE BEFORE PREGNANCY 95 0.0139
539 VOMITING 6525 0.0139
540 HAND FRACTURE 98 0.0138
541 PLATELET COUNT INCREASED 179 0.0137
542 PSORIASIS 1782 0.0136
543 MULTIPLE FRACTURES 224 0.0136
544 FURUNCLE 108 0.0136
545 NEPHROLITHIASIS 625 0.0136
546 TOE AMPUTATION 69 0.0136
547 DECREASED APPETITE 3154 0.0136
548 FREQUENT BOWEL MOVEMENTS 366 0.0135
549 SKIN MASS 90 0.0135
550 HERNIA 259 0.0134
551 QUALITY OF LIFE DECREASED 179 0.0133
552 EYE DISORDER 438 0.0133
553 ORGANISING PNEUMONIA 66 0.0133
554 OROPHARYNGEAL PAIN 1225 0.0132
555 MUSCLE SPASMS 2428 0.0132
556 SPINAL OSTEOARTHRITIS 115 0.0131
557 ABDOMINAL PAIN 3044 0.0131
558 RASH MACULO-PAPULAR 291 0.0131
559 LABORATORY TEST ABNORMAL 386 0.0131
560 COMPRESSION FRACTURE 70 0.0130
561 ALTERED STATE OF CONSCIOUSNESS 283 0.0130
562 RHINITIS 105 0.0130
563 DRY EYE 645 0.0129
564 DIABETES MELLITUS 982 0.0129
565 LYMPHOMA 198 0.0128
566 UNDERDOSE 931 0.0127
567 DRUG EFFECT DECREASED 685 0.0127
568 MUSCULOSKELETAL DISCOMFORT 218 0.0127
569 GINGIVAL BLEEDING 172 0.0126
570 DYSPNOEA 7104 0.0125
571 SPINAL PAIN 147 0.0125
572 WHITE BLOOD CELL COUNT DECREASED 1358 0.0125
573 NEEDLE ISSUE 364 0.0125
574 ASTHENIA 4695 0.0125
575 VISUAL IMPAIRMENT 1543 0.0124
576 INFLUENZA 1388 0.0124
577 BACK PAIN 2873 0.0124
578 SKIN ATROPHY 71 0.0123
579 PHLEBITIS 63 0.0123
580 ACCIDENT 146 0.0122
581 DIARRHOEA 7817 0.0121
582 GASTROINTESTINAL INFECTION 108 0.0120
583 RECTAL HAEMORRHAGE 516 0.0120
584 HYPERTRIGLYCERIDAEMIA 70 0.0119
585 INCREASED TENDENCY TO BRUISE 110 0.0119
586 INTERVERTEBRAL DISC PROTRUSION 261 0.0119
587 SPINAL FRACTURE 239 0.0119
588 DECREASED IMMUNE RESPONSIVENESS 117 0.0119
589 INJECTION SITE EXTRAVASATION 147 0.0119
590 CATARACT OPERATION 70 0.0118
591 RESPIRATORY TRACT INFECTION 306 0.0117
592 DENTAL CARIES 129 0.0116
593 PHARYNGITIS STREPTOCOCCAL 126 0.0116
594 HAEMATEMESIS 294 0.0116
595 HYPOCALCAEMIA 219 0.0116
596 ORAL PAIN 259 0.0116
597 MENISCUS INJURY 71 0.0115
598 DEPRESSION 2617 0.0115
599 GROIN PAIN 101 0.0115
600 BLOOD TEST ABNORMAL 161 0.0114
601 RENAL CYST 91 0.0114
602 TACHYCARDIA 1011 0.0114
603 HEART RATE INCREASED 1118 0.0113
604 CONJUNCTIVITIS 209 0.0113
605 CHOLECYSTITIS 133 0.0112
606 URINARY TRACT INFECTION 1904 0.0112
607 SEASONAL ALLERGY 157 0.0111
608 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 608 0.0111
609 IMMUNE SYSTEM DISORDER 146 0.0111
610 PANCREATITIS 585 0.0111
611 ANGIOPATHY 62 0.0111
612 PRODUCTIVE COUGH 528 0.0110
613 ROTATOR CUFF SYNDROME 142 0.0110
614 STAPHYLOCOCCAL INFECTION 364 0.0110
615 TENDON RUPTURE 136 0.0110
616 POLYP 72 0.0110
617 VITAMIN D DEFICIENCY 107 0.0110
618 DRUG EFFECT INCOMPLETE 398 0.0109
619 THROMBOCYTOPENIA 1224 0.0109
620 SKIN LESION 300 0.0109
621 PELVIC FRACTURE 85 0.0109
622 MUSCLE STRAIN 94 0.0109
623 SYRINGE ISSUE 190 0.0108
624 RALES 63 0.0108
625 SCRATCH 114 0.0108
626 EYE HAEMORRHAGE 144 0.0108
627 FALL 3581 0.0107
628 NEUTROPHIL COUNT INCREASED 110 0.0107
629 EMPHYSEMA 108 0.0107
630 NAUSEA 8457 0.0107
631 STENT PLACEMENT 86 0.0107
632 UPPER LIMB FRACTURE 212 0.0106
633 LUNG INFECTION 164 0.0105
634 COLITIS ULCERATIVE 470 0.0105
635 DEEP VEIN THROMBOSIS 679 0.0104
636 HYPOTHYROIDISM 332 0.0104
637 NEUTROPHIL COUNT DECREASED 423 0.0104
638 ANAPHYLACTIC SHOCK 267 0.0103
639 NEURALGIA 251 0.0103
640 ASCITES 303 0.0103
641 DIPLOPIA 267 0.0103
642 GASTRIC ULCER 195 0.0102
643 LYMPHOCYTE COUNT DECREASED 181 0.0102
644 DIZZINESS 5101 0.0102
645 LYMPHOPENIA 143 0.0101
646 WRIST FRACTURE 120 0.0100
647 DERMATITIS 209 0.0100
648 ABDOMINAL DISTENSION 1038 0.0099
649 RED BLOOD CELL COUNT DECREASED 284 0.0099
650 SPUTUM DISCOLOURED 94 0.0099
651 PRESYNCOPE 240 0.0099
652 LYMPHADENOPATHY 349 0.0098
653 COVID-19 1715 0.0098
654 RIB FRACTURE 201 0.0098
655 PNEUMONITIS 264 0.0097
656 ERYTHEMA 1992 0.0097
657 CORONAVIRUS INFECTION 64 0.0097
658 NASAL CONGESTION 567 0.0096
659 DEAFNESS 251 0.0096
660 COUGH 2686 0.0096
661 RESPIRATORY TRACT CONGESTION 152 0.0096
662 NEUTROPENIA 1299 0.0095
663 NERVE COMPRESSION 88 0.0095
664 FACIAL PARALYSIS 81 0.0095
665 PHARYNGEAL OEDEMA 146 0.0095
666 PULMONARY EMBOLISM 901 0.0095
667 HEART RATE IRREGULAR 214 0.0095
668 MOVEMENT DISORDER 304 0.0095
669 UPPER-AIRWAY COUGH SYNDROME 78 0.0095
670 AORTIC ANEURYSM 72 0.0095
671 CARDIAC MURMUR 81 0.0094
672 SKIN DISORDER 312 0.0093
673 DECUBITUS ULCER 76 0.0093
674 RHINORRHOEA 602 0.0093
675 ORAL CANDIDIASIS 122 0.0093
676 THROMBOSIS 745 0.0093
677 FEELING HOT 565 0.0092
678 HYPERHIDROSIS 1181 0.0092
679 VIRAL INFECTION 305 0.0092
680 TINNITUS 421 0.0092
681 NEOPLASM 105 0.0091
682 HIATUS HERNIA 118 0.0091
683 BLOOD CREATININE INCREASED 594 0.0091
684 TUMOUR LYSIS SYNDROME 80 0.0091
685 APPENDICITIS 84 0.0090
686 ACUTE RESPIRATORY FAILURE 173 0.0090
687 BLOOD POTASSIUM INCREASED 145 0.0089
688 PRODUCT STORAGE ERROR 779 0.0089
689 CHOLELITHIASIS 290 0.0088
690 HYPERTENSIVE CRISIS 98 0.0088
691 EYE INFLAMMATION 84 0.0088
692 FAECES SOFT 64 0.0088
693 PHARYNGEAL SWELLING 86 0.0088
694 LOW DENSITY LIPOPROTEIN INCREASED 68 0.0088
695 INTENTIONAL PRODUCT MISUSE 767 0.0088
696 HEPATIC CYTOLYSIS 111 0.0087
697 HIP FRACTURE 280 0.0087
698 HAEMATOCRIT DECREASED 172 0.0087
699 GINGIVAL PAIN 69 0.0087
700 EYE PAIN 489 0.0087
701 OVARIAN CYST 86 0.0086
702 HYPOTENSION 1725 0.0086
703 THROAT IRRITATION 384 0.0085
704 PLEURAL EFFUSION 516 0.0085
705 RENAL IMPAIRMENT 709 0.0084
706 SLEEP APNOEA SYNDROME 161 0.0084
707 RESPIRATORY FAILURE 612 0.0084
708 HYPERLIPIDAEMIA 100 0.0084
709 EMBOLISM 69 0.0083
710 MUSCULOSKELETAL CHEST PAIN 128 0.0083
711 LOSS OF CONSCIOUSNESS 1058 0.0082
712 HYPOKALAEMIA 381 0.0082
713 FLANK PAIN 77 0.0082
714 NEOPLASM MALIGNANT 545 0.0082
715 OPTIC NEURITIS 74 0.0081
716 ATELECTASIS 78 0.0081
717 HAEMOGLOBIN DECREASED 826 0.0080
718 BURNING SENSATION 564 0.0080
719 PULMONARY CONGESTION 106 0.0080
720 HEPATOMEGALY 78 0.0079
721 DEVICE RELATED INFECTION 122 0.0079
722 PLATELET COUNT DECREASED 835 0.0078
723 FEEDING DISORDER 158 0.0078
724 DRY THROAT 79 0.0078
725 BLOOD IRON DECREASED 92 0.0077
726 HAEMATURIA 264 0.0077
727 CHILLS 899 0.0077
728 CLOSTRIDIUM DIFFICILE INFECTION 167 0.0076
729 DRUG RESISTANCE 194 0.0075
730 LACERATION 71 0.0075
731 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 72 0.0075
732 IRON DEFICIENCY ANAEMIA 69 0.0075
733 SPLENOMEGALY 87 0.0074
734 EPISTAXIS 554 0.0074
735 BRAIN NEOPLASM 68 0.0074
736 HYPOXIA 260 0.0074
737 ANXIETY 2098 0.0074
738 PRODUCT QUALITY ISSUE 998 0.0073
739 CARDIO-RESPIRATORY ARREST 307 0.0073
740 PERITONITIS 152 0.0073
741 NEUROTOXICITY 128 0.0073
742 FOETAL EXPOSURE DURING PREGNANCY 585 0.0072
743 COLON CANCER 107 0.0072
744 MYALGIA 1203 0.0071
745 SUBARACHNOID HAEMORRHAGE 72 0.0071
746 DISEASE PROGRESSION 836 0.0071
747 SYNCOPE 703 0.0070
748 SKIN CANCER 151 0.0070
749 INTERNAL HAEMORRHAGE 80 0.0070
750 BLOOD TRIGLYCERIDES INCREASED 122 0.0069
751 SCAR 118 0.0069
752 THERAPY INTERRUPTED 492 0.0069
753 LOCAL SWELLING 119 0.0068
754 EOSINOPHILIA 119 0.0068
755 PANCREATITIS ACUTE 152 0.0068
756 HYPERBILIRUBINAEMIA 70 0.0068
757 COMA 321 0.0067
758 HAEMORRHOIDS 130 0.0067
759 DYSPHONIA 389 0.0066
760 GASTROINTESTINAL PAIN 73 0.0066
761 PERIPHERAL COLDNESS 90 0.0065
762 PROTEINURIA 124 0.0065
763 BRONCHOSPASM 93 0.0065
764 COLITIS 244 0.0064
765 SWELLING FACE 417 0.0064
766 ANGINA PECTORIS 183 0.0064
767 CEREBRAL INFARCTION 156 0.0064
768 APHONIA 89 0.0064
769 BLADDER DISORDER 63 0.0063
770 EXPOSURE VIA SKIN CONTACT 164 0.0063
771 TEMPERATURE INTOLERANCE 65 0.0063
772 PANCYTOPENIA 352 0.0063
773 HAEMATOMA 163 0.0063
774 ATRIAL FIBRILLATION 611 0.0063
775 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 288 0.0062
776 BLOOD URINE PRESENT 117 0.0062
777 DEVICE MALFUNCTION 428 0.0061
778 GASTRITIS 159 0.0060
779 AGRANULOCYTOSIS 112 0.0060
780 MYELODYSPLASTIC SYNDROME 87 0.0060
781 ABDOMINAL PAIN LOWER 152 0.0060
782 PULMONARY OEDEMA 269 0.0060
783 CARDIOVASCULAR DISORDER 152 0.0060
784 SARS-COV-2 TEST POSITIVE 79 0.0060
785 GOUT 107 0.0060
786 HEPATOCELLULAR INJURY 84 0.0059
787 SURGERY 347 0.0059
788 ILLNESS 606 0.0059
789 TOOTH EXTRACTION 73 0.0059
790 MYOCARDITIS 67 0.0058
791 SWOLLEN TONGUE 181 0.0058
792 SKIN DISCOLOURATION 266 0.0058
793 SCAB 66 0.0058
794 ENCEPHALOPATHY 142 0.0058
795 GAMMA-GLUTAMYLTRANSFERASE INCREASED 127 0.0057
796 PRODUCT ADMINISTRATION ERROR 115 0.0057
797 RENAL DISORDER 263 0.0056
798 RENAL FAILURE 749 0.0056
799 DYSPNOEA EXERTIONAL 212 0.0056
800 DEVICE ISSUE 499 0.0056
801 LUNG NEOPLASM MALIGNANT 228 0.0055
802 SHOCK 127 0.0055
803 CARDIAC FAILURE 443 0.0055
804 RESTLESS LEGS SYNDROME 100 0.0055
805 BREAST CANCER 511 0.0055
806 LEUKOCYTOSIS 99 0.0055
807 DIABETES MELLITUS INADEQUATE CONTROL 96 0.0054
808 MYOCARDIAL INFARCTION 939 0.0054
809 DISEASE RECURRENCE 255 0.0054
810 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 157 0.0054
811 PRODUCT PREPARATION ERROR 110 0.0053
812 GALLBLADDER DISORDER 95 0.0053
813 INCORRECT PRODUCT ADMINISTRATION DURATION 115 0.0053
814 SNEEZING 119 0.0053
815 RETCHING 113 0.0053
816 BLOOD BILIRUBIN INCREASED 143 0.0053
817 BLOOD PRESSURE DECREASED 351 0.0053
818 SPINAL OPERATION 65 0.0053
819 HAEMOPTYSIS 147 0.0053
820 SKIN FISSURES 102 0.0052
821 PREMATURE DELIVERY 83 0.0052
822 MUCOSAL INFLAMMATION 136 0.0052
823 PULMONARY HYPERTENSION 107 0.0051
824 HEAD INJURY 162 0.0051
825 SENSORY DISTURBANCE 82 0.0051
826 POST PROCEDURAL COMPLICATION 98 0.0051
827 INJECTION SITE PRURITUS 341 0.0051
828 PRODUCT DOSE OMISSION ISSUE 1490 0.0051
829 ISCHAEMIC STROKE 90 0.0050
830 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 263 0.0050
831 THROAT TIGHTNESS 136 0.0050
832 HUNGER 70 0.0050
833 HOT FLUSH 377 0.0050
834 PRURITUS GENERALISED 108 0.0050
835 MUSCLE TIGHTNESS 80 0.0049
836 CONSTIPATION 1077 0.0049
837 PERICARDIAL EFFUSION 113 0.0049
838 BLOOD ALKALINE PHOSPHATASE INCREASED 121 0.0049
839 IMPAIRED QUALITY OF LIFE 70 0.0049
840 HAEMATOCHEZIA 268 0.0049
841 CHEST DISCOMFORT 496 0.0048
842 VERTIGO 293 0.0048
843 INJECTION SITE RASH 147 0.0048
844 TACHYPNOEA 65 0.0048
845 ANAEMIA 897 0.0047
846 CRYING 170 0.0047
847 BONE MARROW FAILURE 95 0.0047
848 BLOOD UREA INCREASED 78 0.0047
849 PALPITATIONS 544 0.0046
850 PRODUCT DISPENSING ERROR 101 0.0046
851 THERAPY CESSATION 235 0.0046
852 ACUTE MYOCARDIAL INFARCTION 134 0.0045
853 HAEMORRHAGE 473 0.0045
854 SOMNOLENCE 900 0.0045
855 HYPOACUSIS 192 0.0045
856 ACUTE KIDNEY INJURY 672 0.0044
857 CARDIAC DISORDER 410 0.0044
858 OVERDOSE 943 0.0044
859 ANGIOEDEMA 193 0.0044
860 RESPIRATORY DISTRESS 120 0.0043
861 FEELING COLD 121 0.0043
862 HOSPITALISATION 664 0.0043
863 INFLUENZA LIKE ILLNESS 349 0.0042
864 MIDDLE INSOMNIA 79 0.0042
865 TREATMENT NONCOMPLIANCE 230 0.0042
866 LACRIMATION INCREASED 127 0.0042
867 CEREBROVASCULAR ACCIDENT 710 0.0042
868 OSTEONECROSIS 137 0.0042
869 PRODUCT PRESCRIBING ERROR 99 0.0042
870 DYSSTASIA 121 0.0041
871 DEMENTIA 115 0.0041
872 TRANSIENT ISCHAEMIC ATTACK 138 0.0041
873 SINUS DISORDER 81 0.0041
874 CEREBRAL HAEMORRHAGE 145 0.0040
875 BLOOD LACTATE DEHYDROGENASE INCREASED 64 0.0040
876 PELVIC PAIN 73 0.0040
877 URINARY INCONTINENCE 119 0.0040
878 NEUROPATHY PERIPHERAL 381 0.0040
879 NERVOUS SYSTEM DISORDER 124 0.0040
880 BLOOD CREATINE PHOSPHOKINASE INCREASED 114 0.0040
881 ACCIDENTAL EXPOSURE TO PRODUCT 403 0.0039
882 MELAENA 86 0.0039
883 ARRHYTHMIA 185 0.0039
884 POOR QUALITY SLEEP 84 0.0039
885 BONE PAIN 228 0.0039
886 ACNE 295 0.0039
887 PNEUMONIA ASPIRATION 97 0.0039
888 PALLOR 105 0.0039
889 INTENTIONAL DOSE OMISSION 109 0.0038
890 HEPATIC FAILURE 115 0.0038
891 LIP SWELLING 127 0.0038
892 VISION BLURRED 523 0.0038
893 INJECTION SITE BRUISING 303 0.0038
894 MULTI-ORGAN FAILURE 65 0.0038
895 ACTIVITIES OF DAILY LIVING IMPAIRED 74 0.0037
896 FEELING ABNORMAL 894 0.0037
897 COAGULOPATHY 62 0.0037
898 FEELING JITTERY 70 0.0037
899 INJECTION SITE ERYTHEMA 455 0.0037
900 EMOTIONAL DISORDER 113 0.0037
901 TREMOR 600 0.0036
902 APHASIA 107 0.0035
903 DYSURIA 130 0.0035
904 DYSPHAGIA 334 0.0035
905 OCULAR HYPERAEMIA 166 0.0035
906 INJECTION SITE SWELLING 268 0.0035
907 BLOOD POTASSIUM DECREASED 105 0.0035
908 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 89 0.0035
909 FLUSHING 350 0.0034
910 DRUG INTERACTION 542 0.0034
911 PRODUCT DOSE OMISSION 223 0.0034
912 MYELOSUPPRESSION 123 0.0034
913 BLOOD PRESSURE ABNORMAL 67 0.0034
914 UNEVALUABLE EVENT 251 0.0033
915 INCREASED APPETITE 63 0.0033
916 CHROMATURIA 74 0.0033
917 CARDIAC ARREST 270 0.0033
918 PREMATURE BABY 98 0.0033
919 ABASIA 80 0.0032
920 ECZEMA 169 0.0032
921 EYE SWELLING 119 0.0032
922 BRADYCARDIA 169 0.0032
923 FLATULENCE 180 0.0032
924 CARDIAC FAILURE CONGESTIVE 250 0.0031
925 FEBRILE NEUTROPENIA 206 0.0031
926 HYPERGLYCAEMIA 113 0.0031
927 INJECTION SITE URTICARIA 75 0.0031
928 URINARY RETENTION 102 0.0031
929 PRODUCT DOSE OMISSION IN ERROR 85 0.0030
930 GASTROINTESTINAL HAEMORRHAGE 248 0.0030
931 SPEECH DISORDER 155 0.0030
932 PANIC ATTACK 106 0.0029
933 BALANCE DISORDER 250 0.0029
934 DEATH 2442 0.0028
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 571 0.0028
936 PROCEDURAL PAIN 78 0.0028
937 POLLAKIURIA 117 0.0028
938 ABORTION SPONTANEOUS 112 0.0028
939 INTESTINAL OBSTRUCTION 105 0.0028
940 EYE IRRITATION 160 0.0028
941 DEHYDRATION 370 0.0028
942 HYPOGLYCAEMIA 134 0.0028
943 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 490 0.0027
944 THERAPEUTIC RESPONSE SHORTENED 90 0.0027
945 EYE PRURITUS 91 0.0027
946 HYPONATRAEMIA 151 0.0027
947 JAUNDICE 72 0.0027
948 MOOD SWINGS 85 0.0027
949 GASTRIC CANCER 64 0.0025
950 SEIZURE 291 0.0025
951 NERVOUSNESS 129 0.0025
952 DEVICE DIFFICULT TO USE 163 0.0025
953 PANCREATIC CARCINOMA 70 0.0024
954 LETHARGY 136 0.0024
955 DEPRESSED MOOD 124 0.0023
956 DRY SKIN 291 0.0022
957 BLOOD GLUCOSE INCREASED 410 0.0022
958 TOXICITY TO VARIOUS AGENTS 366 0.0022
959 LACTIC ACIDOSIS 70 0.0022
960 DRUG DEPENDENCE 337 0.0021
961 MENTAL DISORDER 91 0.0021
962 COGNITIVE DISORDER 96 0.0021
963 MULTIPLE SCLEROSIS 98 0.0020
964 CHRONIC KIDNEY DISEASE 155 0.0020
965 MALIGNANT NEOPLASM PROGRESSION 202 0.0020
966 RASH MACULAR 68 0.0019
967 HYPERKALAEMIA 68 0.0019
968 INJECTION SITE HAEMORRHAGE 148 0.0019
969 DEVICE USE ERROR 64 0.0018
970 DEVICE DISLOCATION 79 0.0018
971 ELECTROCARDIOGRAM QT PROLONGED 65 0.0018
972 SUICIDAL IDEATION 164 0.0018
973 INJECTION SITE MASS 65 0.0018
974 PROSTATE CANCER 136 0.0017
975 INJECTION SITE PAIN 514 0.0017
976 HALLUCINATION 125 0.0017
977 DISORIENTATION 65 0.0016
978 DEPRESSED LEVEL OF CONSCIOUSNESS 64 0.0016
979 DEVICE BREAKAGE 64 0.0016
980 DRUG DOSE OMISSION 258 0.0016
981 DYSGEUSIA 115 0.0015
982 BLOOD GLUCOSE DECREASED 74 0.0015
983 SKIN IRRITATION 66 0.0014
984 AGITATION 100 0.0014
985 SKIN EXFOLIATION 105 0.0012
986 IRRITABILITY 71 0.0012
987 BLADDER CANCER 68 0.0012
988 SKIN BURNING SENSATION 65 0.0009
989 INCORRECT DOSE ADMINISTERED 204 0.0009